A Randomized, Placebo-controlled Trial to Evaluate the Long-term (ie, Maintenance) Efficacy of Oral Aripiprazole in the Treatment of Pediatric Subjects with Tourette’s Disorder

Registry ID

EUCTR2018-002270-48

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE4

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.

Start date

2019-01-31

Completion date

2020-05-18

Last update

2026-08-16

Conditions

• Tourette’s Disorder

Summary

The primary objective of the trial is to evaluate the long-term efficacy of aripiprazole once-daily treatment with oral tablets in pediatric subjects with TD.

Locations

• , , Hungary

View on source registry